Jie Lian

Jie Lian

Auto-generated profile, based on publicly available information

Jie Lian

Life Science Institute, Guangxi Medical University, Nanning, China

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 October 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
PCPing Cui
Ping Cui
JLJie Lian
Jie Lian
YLYang Liu
Yang Liu
DZDongsheng Zhang
Dongsheng Zhang
YLYao Lin
Yao Lin
HLHao Liang
Hao Liang
SHP-1, a nonreceptor protein tyrosine phosphatase encoded by ptpn6, has been regarded as a regulatory protein of hematopoietic cell biology for years. However, there is now increasing evidence to support its role in tumors. Thus, the role of ptpn6 for prognosis and immune regulation across 33 tumors was investigated, aiming to explore its functional heterogeneity and clinical significance in pan-cancer. Differential expression of ptpn6 was found between cancer and adjacent normal tissues, and its expression was significantly correlated with the prognosis of tumor patients. In most cancers, ptpn6 expression was significantly associated with immune infiltration. This was further confirmed by ptpn6-related genes/proteins enrichment analysis. Additionally, genetic alterations in ptpn6 was observed in most cancers. As for epigenetic changes, it’s phosphorylation levels significantly altered in 6 tumors, while methylation levels significantly altered in 12 tumors. Notably, the methylation levels of ptpn6 were significantly decreased in 11 tumors, accompanied by its increased expression in 8 of them, suggesting that the hypomethylation may be related to its increased expression. Our results show that ptpn6 plays a specific role in tumor immunity and exerts a pleiotropic effect in a variety of tumors. It can serve as a prognostic factor for some cancers. Especially in LGG, KIRC, UCS and TGCT, the increased expression of ptpn6 is associated with poor prognosis and high immune infiltration. This aids in understanding the role of ptpn6 in tumor biology, and can provide insight into presenting a potential biomarker for poor prognosis and immune infiltration in cancers.

1 August 2025 in JMIR Preprints
Verified
Preprint
Open access
RYRu Yao
Ru Yao
YQYang Qu
Yang Qu
JZJiahui Zhang
Jiahui Zhang
XZXingtong Zhou
Xingtong Zhou
JLJie Lian
Jie Lian
QSQiang Sun
Qiang Sun
BACKGROUND Rare breast diseases are infrequently encountered in clinical training, leading to gaps in medical students’ knowledge. Large Language Models (LLMs) show promise in assisting educators, particularly for complex topics like rare diseases where standardized teaching materials are scarce. OBJECTIVE This study aims to evaluate and compare the capabilities of prominent LLMs in generating lesson plans for rare breast diseases targeted at clinical medical students. METHODS Ten representative rare breast diseases were selected based on prior bibliometric analysis and expert consensus. Four LLMs - ChatGPT-4o, Grok3, Deepseek R1, and Doubao - were prompted in Chinese to produce structured teaching plans. Three experienced breast surgery teaching faculty evaluated the generated lesson plans using a standardized score (0-5 points) across six dimensions: Generation Capability, Medical Accuracy, Completeness, Readability, Applicability, and Interactivity. Quantitative scores were compared statistically. RESULTS All LLMs successfully generated lesson plans, but with significant differences across all evaluated dimensions (P < 0.001). Deepseek consistently achieved the highest mean scores in all 6 dimensions. ChatGPT ranked second, also demonstrating strong performance, particularly in Generation Capability and Completeness. Grok3 and Doubao showed moderate performance, with Doubao scoring relatively higher in Readability and Accuracy, while Grok3 performed better in Applicability and Interactivity compared to Doubao. CONCLUSIONS LLMs, particularly advanced models like Deepseek and ChatGPT, demonstrate significant potential in assisting the generation of high-quality lesson plans for rare breast diseases, while variability in quality and occasional inaccuracies necessitate expert review. Integration of LLM-generated materials into medical curricula holds promise for enhancing rare disease education.